comparemela.com

PARIS, France, April 18th, 2023, 08:30 am CET - Pharnext SA (FR001400BV89 - ALPHA) (the "Company"), an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative

Related Keywords

United Kingdom ,United States ,France ,Paris ,France General ,Fabreguettes Leib ,Euronext Growth Stock Exchange ,United Kingdom Charity ,Schwartz ,Friday April ,Saturday April ,Kingdom Conference ,Presse Financi ,Pharnext ,Supports ,Nline ,023 ,Conference ,Imtuk ,Charity ,Edicated ,Supporting ,People ,Diving ,Charcot ,Marie ,Tooth ,Disease ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.